Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €71.00 by Credit Suisse Group

Credit Suisse Group set a €71.00 ($82.56) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report report published on Friday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Other research analysts have also recently issued research reports about the stock. Jefferies Financial Group set a €69.00 ($80.23) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Wednesday, September 18th. Goldman Sachs Group set a €80.00 ($93.02) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Monday, October 14th. Nord/LB set a €82.00 ($95.35) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, August 1st. UBS Group set a €92.00 ($106.98) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, July 30th. Finally, HSBC set a €77.00 ($89.53) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Fresenius Medical Care AG & Co. KGaA currently has a consensus rating of Buy and a consensus price target of €79.03 ($91.90).

FME opened at €61.10 ($71.05) on Friday. The company has a debt-to-equity ratio of 105.17, a quick ratio of 0.63 and a current ratio of 0.99. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €55.44 ($64.47) and a fifty-two week high of €76.68 ($89.16). The firm’s fifty day moving average is €61.17 and its 200 day moving average is €66.64. The stock has a market cap of $18.50 billion and a price-to-earnings ratio of 15.16.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: How is a price target determined?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit